Cargando…
Use of cell-free signals as biomarkers for early and easy prediction of preeclampsia
INTRODUCTION: Preeclampsia (PE) is a leading cause of maternal and perinatal morbidity worldwide. However, current methods of screening are complicated and require special skill sets. In this observational study of prospectively collected samples, we wanted to evaluate if cell-free (cf) DNA could be...
Autores principales: | Gekas, Jean, Boomer, Theresa Hopkins, Rodrigue, Marc-André, Jinnett, Kristine N., Bhatt, Sucheta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244626/ https://www.ncbi.nlm.nih.gov/pubmed/37293304 http://dx.doi.org/10.3389/fmed.2023.1191163 |
Ejemplares similares
-
Patient attitudes and preferences about expanded noninvasive prenatal testing
por: Dubois, Marie-Line, et al.
Publicado: (2023) -
Natriuretic peptide biomarkers in the imminent development of preeclampsia
por: Marek-Iannucci, Stefanie, et al.
Publicado: (2023) -
Effects of maternal characteristics and medical history on first trimester biomarkers for preeclampsia
por: Torres-Torres, Johnatan, et al.
Publicado: (2023) -
Afamin: an early predictor of preeclampsia
por: Köninger, Angela, et al.
Publicado: (2018) -
Serum peptidomic screening identified circulating peptide biomarkers predictive for preeclampsia
por: Zhao, Shenglong, et al.
Publicado: (2022)